Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Associations of residential greenness with bone mineral density and osteoporosis: the modifying effect of genetic susceptibilityAnnals of the rheumatic diseases, 2024-05, Vol.83 (5), p.669-676 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2023-224941 ;PMID: 38443139Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?Annals of the rheumatic diseases, 2024-02, p.ard-2023-224103 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2023-224103 ;PMID: 38378236Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing studyAnnals of the rheumatic diseases, 2024-02, Vol.83 (2), p.253-260 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2023-224732 ;PMID: 37918895Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
HLA-B27, axial spondyloarthritis and survivalAnnals of the rheumatic diseases, 2023-12, Vol.82 (12), p.1558-1567 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2023-224434 ;PMID: 37679034Full text available |
|
5 |
Material Type: Article
|
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targetsAnnals of the rheumatic diseases, 2023-08, Vol.82 (8), p.999-1014 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-223741 ;PMID: 36792346Full text available |
|
6 |
Material Type: Article
|
Annals of the Rheumatic Diseases collection on lupus nephritis (2019–2022): novel insights and advances in therapyAnnals of the rheumatic diseases, 2023-06, Vol.82 (6), p.729-733 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2023-223880 ;PMID: 37094880Full text available |
|
7 |
Material Type: Article
|
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingAnnals of the rheumatic diseases, 2023-06, Vol.82 (6), p.837-847 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-223697 ;PMID: 36797040Full text available |
|
8 |
Material Type: Article
|
POS0820 SEX-EQTL ANALYSIS REVEALS A SIGNIFICANT SEX-BIAS IN THE EFFECTS OF SJÖGREN’S SYNDROME ASSOCIATED ALLELES ON GENE TRANSCRIPTIONAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.705-705 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.6230Full text available |
|
9 |
Material Type: Article
|
OP0101 B CELL POLYGENIC RISK SCORES ASSOCIATED WITH ANTI-DSDNA ANTIBODIES AND NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUSAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.68-68 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.6203Full text available |
|
10 |
Material Type: Article
|
POS1468 A HIGH GENETIC RISK OF SLE IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION AND IMPAIRED KIDNEY FUNCTION; A COMBINED OBSERVATIONAL AND MENDELIAN RANDOMIZATION STUDYAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1088-1089 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.5442Full text available |
|
11 |
Material Type: Article
|
AB0139 VALIDATION AND THE CLINICAL UTILITY OF POLYGENIC RISK SCORING IN ASIAN SLEAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1249-1249 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.5903Full text available |
|
12 |
Material Type: Article
|
OP0193 SEX DIMORPHISM ANALYSIS IN A COHORT OF JIA PATIENTS REVEALS DIFFERING GENETIC RISK FACTORS FOR FEMALES AND MALESAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.128-128 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.3537Full text available |
|
13 |
Material Type: Article
|
POS0511 LIFESTYLE MODIFICATION FOR THE PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH GOUTAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.518-518 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.1343Full text available |
|
14 |
Material Type: Article
|
Correspondence on ‘Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden’Annals of the rheumatic diseases, 2023-04, Vol.82 (4), p.e87-e87 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-219894 ;PMID: 33526433Full text available |
|
15 |
Material Type: Article
|
Occupational inhalants, genetics and the respiratory mucosal paradigm for ACPA-positive rheumatoid arthritisAnnals of the rheumatic diseases, 2023-03, Vol.82 (3), p.303-305 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-223286 ;PMID: 36600176Full text available |
|
16 |
Material Type: Article
|
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodiesAnnals of the rheumatic diseases, 2023-02, Vol.82 (2), p.235-245 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. 2023 ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-222935 ;PMID: 36171069Full text available |
|
17 |
Material Type: Article
|
Response to: ‘Correspondence on ‘Prevotella copri in individuals at risk for rheumatoid arthritis’’ by Sun and NiAnnals of the rheumatic diseases, 2023-02, Vol.82 (2), p.e51-e51 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-219365 ;PMID: 33272958Full text available |
|
18 |
Material Type: Article
|
Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart functionAnnals of the rheumatic diseases, 2022-08, Vol.81 (8), p.1151-1161 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-221714 ;PMID: 35470161Full text available |
|
19 |
Material Type: Article
|
ADAMTS5 as a therapeutic target for osteoarthritis: Mendelian randomisation studyAnnals of the rheumatic diseases, 2022-06, Vol.81 (6), p.903-904 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-222007 ;PMID: 35131763Full text available |
|
20 |
Material Type: Article
|
Response to: ‘Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al’ by Regueiro and GonzalezAnnals of the rheumatic diseases, 2022-03, Vol.81 (3), p.e39-e39 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217064 ;PMID: 32371386Full text available |